Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-29 Purchase |
2022-08-01 6:11 pm |
TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim 10% Owner |
565,000 | $4.72 | $2,666,800 | 15,000 (Indirect) |
View |
| 2022-07-15 Purchase |
2022-07-19 11:28 am |
TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim 10% Owner |
82,580 | $5.6607 | $467,458 | 1,156,953 (Indirect) |
View |
| 2021-11-30 Sale |
2021-12-02 06:30 am |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
29,790 | $0.5353 | $15,947 | 214,368 (Direct) |
View |
| 2021-11-18 Purchase |
2021-11-22 06:30 am |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
1,000,000 | $0.5785 | $578,500 | 2,236,864 (Direct) |
View |
| 2021-08-17 Purchase |
2021-08-19 4:31 pm |
TherapeuticsMD Inc. | TXMD | Ling Karen Director |
33,445 | $0.75 | $25,084 | 130,309 (Direct) |
View |
| 2021-08-17 Purchase |
2021-08-19 06:01 am |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
1,000,000 | $0.725 | $725,000 | 1,236,864 (Direct) |
View |
| 2021-08-16 Purchase |
2021-08-18 06:03 am |
TherapeuticsMD Inc. | TXMD | BISARO PAUL Director |
50,000 | $0.79 | $39,500 | 196,864 (Direct) |
View |
| 2021-08-13 Purchase |
2021-08-17 06:47 am |
TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director |
11,000 | $0.87 | $9,570 | 865,452 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-29 Option Award |
2022-10-03 6:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | MUSING JULES A. Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-09-29 Option Award |
2022-10-03 6:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Ling Karen Director |
5,000 | $0 | 5,000 (Direct) |
View |
Ownership |
2022-09-16 4:49 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Bernick Brian Co-Chief Executive Officer |
0 | $0 | 73,281 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 06:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
1,984 | $0 | 46,722 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 06:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Naughton Gail K Director |
1,984 | $0 | 3,922 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 06:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | MUSING JULES A. Director |
1,984 | $0 | 4,022 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 06:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Russell Angus C. Director |
1,984 | $0 | 5,792 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 06:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Ling Karen Director |
1,984 | $0 | 4,591 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 06:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director |
2,976 | $0 | 20,287 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-22 06:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | BISARO PAUL Director |
1,984 | $0 | 5,922 (Direct) |
View |
Ownership |
2022-07-19 11:14 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim 10% Owner |
0 | $0 | 1,202,627 (Indirect) |
View |
| 2022-03-31 Option Award |
2022-03-31 5:16 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
260,000 | $0 | 260,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-03-31 5:15 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | O'Dowd Hugh Chief Executive Officer |
2,125,000 | $0 | 2,125,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-03-31 5:15 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Chief Business Officer |
260,000 | $0 | 260,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-03-31 5:15 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-28 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Chief Business Officer |
260,000 | $0 | 260,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-28 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | O'Dowd Hugh Chief Executive Officer |
2,125,000 | $0 | 2,125,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-28 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
260,000 | $0 | 260,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-28 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-28 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
260,000 | $0 | 260,000 (Direct) |
View |
| 2022-03-14 Exercise |
2022-03-15 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
230,000 | $0 | 258,908 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 06:30 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
115,000 | $0 | 214,368 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-15 5:20 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Chief Business Officer |
920,000 | $0 | 920,000 (Direct) |
View |
| 2021-09-29 Option Award |
2021-10-01 5:00 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
57,797 | $0 | 57,797 (Direct) |
View |
| 2021-09-29 Other |
2021-10-01 5:00 pm |
2016-06-04 2025-06-04 |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
395,000 | $0 | 57,797 (Direct) |
View |
| 2021-09-29 Option Award |
2021-10-01 5:00 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
38,954 | $0 | 38,954 (Direct) |
View |
| 2021-09-29 Other |
2021-10-01 5:00 pm |
2015-07-09 2024-07-09 |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
290,000 | $0 | 38,954 (Direct) |
View |
| 2021-08-31 Option Award |
2021-08-31 5:30 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | O'Dowd Hugh President |
5,500,000 | $0 | 5,500,000 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 9:39 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Naughton Gail K Director |
96,864 | $0 | 96,864 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 9:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Russell Angus C. Director |
96,864 | $0 | 190,364 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 9:36 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | BISARO PAUL Director |
96,864 | $0 | 146,864 (Direct) |
View |